Cancer is the leading cause of death among people with diabetes in England.
This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The Lancet Diabetes & Endocrinology.
Diabetes affects 4.7 million people in the UK, and is caused by the body being unable to regulate blood sugar levels. Around 90 per cent have type 2 diabetes, which is associated with lifestyle factors such as high blood pressure and excess weight.
The remainder have type 1 diabetes, which is caused by the body attacking the cells that produce insulin, the hormone that controls blood sugar.
In the study, researchers from Imperialís School of Public Health looked at anonymized primary care data from 313,907 people in England with diabetes between 2001-2018, and linked this with death data from the Office of National Statistics.
The study revealed death rates for those with diabetes declined in the study period by 32 per cent for men, and 31 per cent for women.
UK cancer survival rates lagging behind EU
The team explain deaths from heart disease and stroke have reduced across the whole population, including those without diabetes.
Dr Jonathan Pearson-Stuttard, lead author of the study, said: "Improvements in risk factors such as smoking and blood pressure, along with progress in medical treatments have contributed to large falls in deaths from heart disease and stroke. The improvements have been even greater in those with diabetes. This has resulted in vascular conditions accounting for around 25 per cent of all deaths in those with diabetes compared to 45 per cent 20 years ago.
"In contrast, improvements in cancer death rates have been much more modest, with improvements in those with diabetes lagging behind the general population. It is striking that cancer is now the leading cause of death in England among people with diabetes and the leading contributor to excess death compared to those without diabetes. Added to this is the fact the UK continues to lag behind other EU countries in terms of cancer survival rates."
Death rates were higher in those with diabetes compared to those without in almost all causes studied.† Death rates for liver disease and dementia were twice as high in those with diabetes compared to those without in 2018, while respiratory death rates were 80 per cent higher.
Increased diabetes risk
The research team say individuals with diabetes have up to a two-fold increased risk of dementia compared with those without diabetes. The precise link for this is unclear but there are several shared risk factors such as smoking, obesity and poor diet between diabetes and dementia.
The increase in liver disease could be due to the high levels of obesity among people with diabetes, and a higher alcohol consumption.
They add that the reasons for cancer being the leading cause of death are unclear, but could be linked to the fact people with diabetes are more likely to be overweight, and excess weight is a leading risk factor for cancer.
The team also highlight limitations of the study, such as the inability to differentiate between type one and two diabetes in the data, and the fact around 20 per cent of people with diabetes in the UK are undiagnosed.
Biochempeg provides high purity PEG derivatives and PEG linkers which are applied in many fields, including medical research, drug-release, nanotechnology, new materials research, cell culture, and other applications. They are playing an important role in the development of new treatment options for cancer therapy and other disease, such as breast cancer, pancreatic cancer, melanoma, diabetes and so on.
Company: Biochempeg Scientific Inc.
Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA